WHO Warns of Rising Drug Resistance, Seeks Greater Investment in Africa
By Ali Mohammed Zanna, Maiduguri
The World Health Organisation (WHO) has urged iAfrican countries to strengthen their healthcare systems and increase investment in the fight against antimicrobial resistance, warning that the growing problem could undermine decades of medical progress.
WHO Regional Director for Africa Dr Mohamed Janabi appealed in a statement marking the 2026 World Antimicrobial Resistance Awareness Week, scheduled for November 18 to 24.
The campaign, which carries the theme, “One Health, One Action: Prevent AMR Now,” highlights the need for coordinated efforts to protect human, animal and environmental health.
Janabi explained that antimicrobial resistance develops when disease-causing organisms, including bacteria, viruses, fungi and parasites, become resistant to medicines used to treat infections.
He said the problem had become a major public health concern, citing estimates that bacterial antimicrobial resistance was associated with 4.7 million deaths worldwide in 2021.
According to him, sub-Saharan Africa faces the highest rates of deaths associated with antimicrobial resistance, increasing the burden on healthcare facilities and vulnerable households.
He warned that the inappropriate use of antibiotics, inadequate infection control, poor sanitation and improper disposal of medical and agricultural waste were contributing to the spread of resistant organisms.
Despite the challenges, Janabi acknowledged improvements in the African region, stating that all 47 WHO member countries had developed national action plans to address antimicrobial resistance.
He said 44 countries had the capacity to conduct susceptibility testing for priority bacterial infections, while 36 had adopted WHO guidelines on antibiotic classification to encourage appropriate prescriptions.
The regional director also noted an increase in countries with functional One Health coordination mechanisms, from 15 in 2023 to 29 in 2026.
He called on governments to move beyond policy commitments by providing sustainable funding for laboratories, surveillance programmes and infection prevention initiatives.
Janabi also emphasised the importance of ensuring access to safe and effective medicines, while discouraging unnecessary prescriptions and misuse of antibiotics.
He urged medical practitioners, animal health workers and agricultural professionals to adopt responsible practices in the use of antimicrobial medicines.
The WHO official further encouraged the media, educators, young people and community leaders to educate the public on preventive measures, including vaccination, regular handwashing and seeking professional medical advice before using antibiotics.
He warned against sharing medicines or using leftover antibiotics without proper medical guidance.
Janabi reaffirmed WHO’s commitment to working with governments and international partners to strengthen regional efforts against antimicrobial resistance.
He stressed that protecting the effectiveness of essential medicines requires sustained action from governments, health institutions and individuals, noting that responsible decisions today would help safeguard medical treatment for future generations.

